Positive for serotype | Total (n = 40) | Age < 75 (n = 28) | Age ≥ 75 (n = 12) | OR (95 % IC) |
---|---|---|---|---|
1 | 4 (10.0) | 0 (0.0) | 4 (33.33) | NE |
3 | 1 (2.5) | 1 (3.57) | 0 (0.0) | NE |
4 | 7 (17.5) | 5 (17.86) | 2 (16.67) | 0.92 (0.152–5.566) |
6A | 2 (5.0) | 2 (7.14) | 0 (0.0) | NE |
9 | 4 (10.0) | 3 (10.71) | 1 (8.33) | 0.758 (0.071–8.118) |
19A | 1 (2.5) | 1 (3.57) | 0 (0.0) | NE |
19 F | 32 (80.0) | 24 (85.71) | 8 (66.67) | 0.333 (0.067–1.652) |
PCV13 serotypes | 34 (85) | 25 (89.29) | 9 (75.0) | 0.36 (0.061–2.119) |
8 | 2 (5.0) | 2 (7.14) | 0 (0.0) | NE |
11 | 2 (5.0) | 2 (7.14) | 0 (0.0) | NE |
12 | 5 (12.5) | 5 (17.86) | 0 (0.0) | NE |
15 | 15 (37.5) | 10 (35.71) | 5 (41.67) | 1.286 (0.322–5.13) |
21 | 1 (2.5) | 1 (3.57) | 0 (0.0) | NE |
22 | 6 (15.0) | 5 (17.86) | 1 (8.33) | 0.418 (0.043–4.024) |
24 | 24 (60.0) | 15 (53.57) | 9 (75.0) | 2.6 (0.578–11.687) |
33 | 4 (10.0) | 2 (7.14) | 2 (16.67) | 2.6 (0.321–21.047) |
35B | 1 (2.5) | 1 (3.57) | 0 (0.0) | NE |
35 F | 1 (2.5) | 1 (3.57) | 0 (0.0) | NE |
Non-PCV13 serotypes | 34 (85.0) | 23 (82.14) | 11 (91.67) | 2.391 (0.249–23.009) |